PROMISE-PET
Standardized PSMA-PET re-defines stage and risk in prostate cancer

News and Events

Press Releases

PROMISE receives German University Medicine Award 2025;
New method improves prognosis and treatment of prostate cancer -
Jennifer Meina. Read the Article


The international PROMISE initiative receives the German University Medicine Award 2025 - DGN Read the Article


UroToday.com - Study Evaluates PSMA-PET-Based Nomograms for Prostate Cancer Prognosis - Kambiz Rahbar.  Read the Article


UroToday.com - ASCO 2025: Updated Prostate Cancer Risk Groups by PSMA-PET PROMISE (PPP2): Results from an International Multi-Centre Registry Study. Read the Article


UroToday.com - Emerging Prognostic Value of Molecular Imaging in Prostate Oncology - Wolfgang Fendler. Read the Article


UroToday.com - SNMMI 2025: Three-Tier Risk Stratification of Prostate Cancer by PSMA-PET PROMISE (PPP2). Read the Article


UroToday.com - AUA 2025: Prostate Cancer Risk Groups by PSMA-PET PROMISE: Results from an International Multi-Center Registry Study. Read the Article


UroToday.com - PSMA and Beyond 2025: PSMA-PET for Overall Survival Outcome Risk Stratification of Prostate Cancer. Read the Article


UroToday.com - ASCO GU 2025: Prostate Cancer Risk Groups by PSMA-PET PROMISE: Results from an International Multi-Center Registry Study. Read the Article


UroToday.com - PPP2: Results from an International Multicentre Registry Study - Beyond the Abstract. Read the Article


UroToday.com - ESMO 2024: PSMA-PET and PROMISE Re-Define Stage and Risk in Patients with Prostate Cancer. Read the Article


VJ Oncology - ASCO 2024: Integration of PSMA-PET into routine clinical practice for patients with prostate cancer - Wolfgang Fendler. Watch the Video


VJ Oncology - ASCO 2024: Assessing the role of PSMA-PET PROMISE nomograms in prostate cancer - Wolfgang Fendler. Watch the Video


UroToday.com - Combining PSMA-PET and PROMISE to Re-Define Disease Stage and Risk in Patients with Prostate Cancer: A Multicentre Retrospective Study - Beyond the Abstract. Read the Article


UroToday.com - PROMISE Criteria: Enhanced Survival Prediction in Prostate Cancer with PSMA PET - Wolfgang Fendler. Read the Article


UroToday.com - PSMA PET and RLT 2024: The Role of PSMA PET in CRPC Patients - Wolfgang Fendler. Read the Article

 

Awards


German University Medicine Award 2025

PROMISE Team. Read the Article


RWGN Award 2024

Madeleine Karpinski. Read the Article 


EANM Young Authors Award 2024

Madeleine Karpinski. Read the Article


Events


EANM 2025 Annual Congress, October 4-8 2025, ICC Barcelona

PROMISE - A Roadmap to PSMA-PET Risk and Response Tools

EANM 2024 Annual Congress, October 19-23 2024, CCH Hamburg
Meet PROMISE Initiative